Stem Cell Transplantation Clinical Trials in Zhengzhou, Henan
4 recruitingZhengzhou, Henan, China
Showing 1–4 of 4 trials
Recruiting
Phase 3
Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial
VenentoclaxALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONMyeloid Malignancies+3 more
First Affiliated Hospital of Zhejiang University186 enrolled18 locationsNCT07396480
Recruiting
Not Applicable
Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT
PreventionHematopoietic Stem Cell TransplantationHemorrhagic Cystitis+1 more
Yi Zhang266 enrolled4 locationsNCT06198517
Recruiting
Phase 2
G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation
Hematopoetic Stem Cell TransplantationHemato-oncologic PatientsMobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)
Fudan University224 enrolled3 locationsNCT07362810
Recruiting
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cell TransplantationCardiovascular EventsTransplant Complication
Peking University People's Hospital10,000 enrolled16 locationsNCT07349498